Company Filing History:
Years Active: 2002
Title: Ibrahim AbouBakr Abdel-Hamid Abdou Ali: Innovator in Premature Ejaculation Treatment
Introduction
Ibrahim AbouBakr Abdel-Hamid Abdou Ali is a notable inventor based in Mansoura, Egypt. He has made significant contributions to the field of medicine, particularly in the treatment of premature ejaculation. His innovative approach has led to the development of a unique method that utilizes phosphodiesterase inhibitors.
Latest Patents
Ibrahim holds a patent for the "Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation." This method involves the administration of a phosphodiesterase inhibitor, specifically targeting Type III, Type IV, or Type V phosphodiesterase. The preferred embodiment of this treatment allows for administration on an "as needed" basis, meaning the drug is taken immediately or several hours prior to sexual activity. Additionally, his patent includes pharmaceutical formulations and packaged kits designed for this treatment.
Career Highlights
Ibrahim is associated with Vivus, Inc., where he continues to work on innovative solutions in the medical field. His dedication to improving patient outcomes through research and development is evident in his work.
Collaborations
Ibrahim has collaborated with notable colleagues, including Leland F Wilson and Paul C Doherty, Jr. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Ibrahim AbouBakr Abdel-Hamid Abdou Ali is a pioneering inventor whose work in the treatment of premature ejaculation showcases his commitment to medical innovation. His contributions are significant in enhancing the quality of life for many individuals.